314 related articles for article (PubMed ID: 26415006)
1. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
3. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
[TBL] [Abstract][Full Text] [Related]
4. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
[TBL] [Abstract][Full Text] [Related]
5. Obliterative portal venopathy without portal hypertension: an underestimated condition.
Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
[TBL] [Abstract][Full Text] [Related]
6. Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.
Biecker E; Trebicka J; Fischer HP; Sauerbruch T; Lammert F
Z Gastroenterol; 2006 May; 44(5):395-8. PubMed ID: 16688657
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.
Guo T; Qian J; Zhu L; Zhou W; Zhu F; Sun G; Fang X
Cell Biochem Biophys; 2012 Nov; 64(2):115-21. PubMed ID: 22707296
[TBL] [Abstract][Full Text] [Related]
8. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
Navale P; Gonzalez RS
Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
[TBL] [Abstract][Full Text] [Related]
9. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
Morris JM; Oien KA; McMahon M; Forrest EH; Morris J; Stanley AJ; Campbell S
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1001-5. PubMed ID: 20075739
[TBL] [Abstract][Full Text] [Related]
10. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension.
Kondo F; Nagao T; Sato T; Tomizawa M; Kondo Y; Matsuzaki O; Wada K; Wakatsuki S; Nagao K; Tsubouchi H; Kobayashi H; Yasumi K; Tsukayama C; Suzuki M
Pathol Res Pract; 1998; 194(7):487-95. PubMed ID: 9728365
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the endothelial genes Notch1 and ephrinB2 in patients with nodular regenerative hyperplasia.
Rothweiler S; Terracciano L; Tornillo L; Dill MT; Heim MH; Semela D
Liver Int; 2014 Apr; 34(4):594-603. PubMed ID: 23870033
[TBL] [Abstract][Full Text] [Related]
12. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
Hartleb M; Gutkowski K; Milkiewicz P
World J Gastroenterol; 2011 Mar; 17(11):1400-9. PubMed ID: 21472097
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
van Asseldonk DP; Jharap B; Verheij J; den Hartog G; Westerveld DB; Becx MC; Russel MG; Engels LG; de Jong DJ; Witte BI; Mulder CJ; van Nieuwkerk CM; Bloemena E; de Boer NK; van Bodegraven AA
Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
[TBL] [Abstract][Full Text] [Related]
14. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations.
Dachman AH; Ros PR; Goodman ZD; Olmsted WW; Ishak KG
AJR Am J Roentgenol; 1987 Apr; 148(4):717-22. PubMed ID: 3548283
[TBL] [Abstract][Full Text] [Related]
15. Nodular regenerative hyperplasia of the liver. A review of 14 cases.
Arvanitaki M; Adler M
Hepatogastroenterology; 2001; 48(41):1425-9. PubMed ID: 11677979
[TBL] [Abstract][Full Text] [Related]
16. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I.
McEntee MF; Wright KN; Wanless I; DeVovo R; Schneider JF; Shull R
Hepatology; 1998 Aug; 28(2):385-90. PubMed ID: 9696001
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
Nzeako UC; Goodman ZD; Ishak KG
Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic and histological problems in the diagnosis of nodular regenerative hyperplasia of the liver.
Solis Herruzo JA; Duran A; Colina F; Santalla F; Garcia-Cabezudo J; Muñoz-Yagüe MT; Morillas JD
Endoscopy; 1985 May; 17(3):105-8. PubMed ID: 3159566
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
Laharie D; Vergniol J; Bioulac-Sage P; Diris B; Poli J; Foucher J; Couzigou P; Drouillard J; de Lédinghen V
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):487-93. PubMed ID: 19940782
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).
Büyük M; Berker N; Bakkaloğlu DV; Şenkal İV; Önal Z; Güllüoğlu M
Hepatol Int; 2024 Jun; 18(3):1011-1019. PubMed ID: 38536628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
